<div class="article">
	<h3>Business Brief -- Diagnostek Inc.:
   Drug Firm Reaches Accord
   To Buy Epic Health Group</h3>
	<div class="article-info">
		<ul>
			<li>Author: null</li>
			<li>Date: 06/22/90</li>
		</ul>
	</div>
	<p class="article-leader">Diagnostek Inc. executed a definitive agreement to acquire
Epic Health Group Inc. for $13.5 million, the companies said.
   They said the price works out to $1.04 a common share and
$7.70 a preferred share. To start the acquisition, a
Diagnostic subsidiary said it would soon begin a tender offer
for Epic shares.</p>
	<div class="article-body"><p>However, Epic said the prices are subject to reduction
under certain circumstances, on the basis of its performance
during a 30-day period of the tender offer.</p>
<p>Diagnostek, based in Albuquerque, N. M., provides drug
cost-control programs, including programs to sell drugs by
mail, and pharmacy-management services. Epic, based in
Elmsford, N.Y., provides mail-order prescription-drug
programs.</p>
<p>Epic closed at 81.25 cents, up 18.75 cents, in
over-the-counter trading. Diagnostek closed at $16.25, up
37.5 cents, in national over-the-counter trading.</p>
<p></p></div>
</div>
